Ani Pharmaceuticals share price today

(ANIP)

Ani Pharmaceuticals share price is $53.35 & ₹4,533.47 as on 21 Dec 2024, 2.30 'hrs' IST

$53.35

▲

-0.91

(-1.68%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Ani Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Ani Pharmaceuticals from India. Also see the sentimental analysis on Indian investors investing in Ani Pharmaceuticals. Get details on the Indian mutual funds that are investing in Ani Pharmaceuticals. Get Analyst recommendations and forecasts along with all the Ani Pharmaceuticals's financials.

Ani Pharmaceuticals share price movements

Today's Low: $53.01
Today's High: $54.51
$53.35
0.64%
Downside
Day's Volatility :2.75%
Upside
2.13%
52 Weeks Low: $52.00
52 Weeks High: $70.81
$53.35
2.53%
Downside
52 Weeks Volatility :26.56%
Upside
24.66%

Ani Pharmaceuticals Returns

Period	Ani Pharmaceuticals Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-11.2%	-11.1%	0.0%
6 Months	-15.07%	-6.0%	0.0%
1 Year	-0.15%	2.7%	0.0%
3 Years	8.39%	0.6%	-19.7%

Ani Pharmaceuticals Key Statistics

in dollars & INR

Previous Close	$54.26
Open	$53.69
Today's High	$54.51
Today's Low	$53.01
Market Capitalization	$1.1B
Today's Volume	$952.9K
52 Week High	$70.81
52 Week Low	$52.0
Revenue TTM	$555.5M
EBITDA	$82.1M
Earnings Per Share (EPS)	$-0.47
Profit Margin	-1.28%
Quarterly Earnings Growth YOY	13.82%
Return On Equity TTM	-1.6%

How to invest in Ani Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in Ani Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Ani Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Ani Pharmaceuticals or ANIP on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Ani Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Ani Pharmaceuticals shares which would translate to 0.016 fractional shares of Ani Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Ani Pharmaceuticals, in just a few clicks!

Returns in Ani Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

Ani Pharmaceuticals investment value today

Current value as on today

₹1,02,346

Returns

₹2,346

(+2.35%)

Returns from Ani Pharmaceuticals Stock

₹150 (false-0.15%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Ani Pharmaceuticals

12%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Ani Pharmaceuticals on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 12% more investors are searching Ani Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in Ani Pharmaceuticals

BlackRock Inc
12.64%
Vanguard Group Inc
6.41%
Goldman Sachs Group Inc
3.41%
State Street Corp
3.35%
Dimensional Fund Advisors, Inc.
3.12%
Ranger Investment Management LP
2.81%

Analyst Recommendation on Ani Pharmaceuticals

Buy

90%Buy

9%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Ani Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 11 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Ani Pharmaceuticals

What analysts predicted

Upside of 47.45%

Current:

$53.35

Target:

$78.67

Insights on Ani Pharmaceuticals

Price Movement
In the last 3 years, ANIP stock has moved up by 11.2%
Increasing Revenue
Revenue is up for the last 4 quarters, 131.65M → 148.33M (in $), with an average increase of 3.9% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, 18.20M → -24.16M (in $), with an average decrease of 534.6% per quarter
ANIP vs HLN (1 yr)
In the last 1 year, Haleon Plc Spon Ads has given 18.3% return, outperforming this stock by 17.9%
Price to Sales
ForANIP every $1 of sales, investors are willing to pay $1.8, whereas for Haleon Plc Spon Ads, the investors are paying $4.0 for every $1 of sales.

Ani Pharmaceuticals Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$201.6M	↑ 13.99%
Net Income	$15.5M	↓ 1539.96%
Net Profit Margin	7.69%	↑ 8.3%

	FY19	Y/Y Change
Revenue	$206.5M	↑ 2.47%
Net Income	$6.1M	↓ 60.67%
Net Profit Margin	2.95%	↓ 4.74%

	FY20	Y/Y Change
Revenue	$208.5M	↑ 0.93%
Net Income	$-22.5M	↓ 470.0%
Net Profit Margin	-10.82%	↓ 13.77%

	FY21	Y/Y Change
Revenue	$216.1M	↑ 3.67%
Net Income	$-42.6M	↑ 88.94%
Net Profit Margin	-19.71%	↓ 8.89%

	FY22	Y/Y Change
Revenue	$316.4M	↑ 46.38%
Net Income	$-47.9M	↑ 12.42%
Net Profit Margin	-15.14%	↑ 4.57%

	FY23	Y/Y Change
Revenue	$486.8M	↑ 53.87%
Net Income	$18.8M	↓ 139.21%
Net Profit Margin	3.86%	↑ 19.0%

	Q2 FY23	Q/Q Change
Revenue	$116.5M	↑ 9.14%
Net Income	$6.2M	↑ 333.98%
Net Profit Margin	5.36%	↑ 4.01%

	Q3 FY23	Q/Q Change
Revenue	$131.8M	↑ 13.11%
Net Income	$9.9M	↑ 59.17%
Net Profit Margin	7.54%	↑ 2.18%

	Q4 FY23	Q/Q Change
Revenue	$131.7M	↓ 0.13%
Net Income	$1.2M	↓ 88.38%
Net Profit Margin	0.88%	↓ 6.66%

	Q1 FY24	Q/Q Change
Revenue	$137.4M	↑ 4.39%
Net Income	$18.2M	↑ 1476.36%
Net Profit Margin	13.25%	↑ 12.37%

	Q2 FY24	Q/Q Change
Revenue	$138.0M	↑ 0.44%
Net Income	$-2.3M	↓ 112.56%
Net Profit Margin	-1.66%	↓ 14.91%

	Q3 FY24	Q/Q Change
Revenue	$148.3M	↑ 7.46%
Net Income	$-24.2M	↑ 956.67%
Net Profit Margin	-16.29%	↓ 14.63%

	FY18	Y/Y Change
Profit	$128.6M	↑ 31.43%

	FY19	Y/Y Change
Profit	$143.4M	↑ 11.54%

	FY20	Y/Y Change
Profit	$121.3M	↓ 15.39%

	FY21	Y/Y Change
Profit	$115.5M	↓ 4.77%

	FY22	Y/Y Change
Profit	$177.6M	↑ 53.73%

	FY23	Y/Y Change
Profit	$305.3M	↑ 71.9%

	Q2 FY23	Q/Q Change
Profit	$74.3M	↑ 7.51%

	Q3 FY23	Q/Q Change
Profit	$83.7M	↑ 12.75%

	Q4 FY23	Q/Q Change
Profit	$63.0M	↓ 24.71%

	Q1 FY24	Q/Q Change
Profit	$73.6M	↑ 16.73%

	Q2 FY24	Q/Q Change
Profit	$65.6M	↓ 10.79%

	Q3 FY24	Q/Q Change
Profit	$85.3M	↑ 29.88%

	FY18	Y/Y Change
Operating Cash Flow	$67.1M	↑ 70.16%
Investing Cash Flow	$-27.4M	↓ 74.65%
Financing Cash Flow	$-27.8M	↓ 138.44%

	FY19	Y/Y Change
Operating Cash Flow	$45.6M	↓ 31.97%
Investing Cash Flow	$-27.5M	↑ 0.62%
Financing Cash Flow	$1.3M	↓ 104.49%

	FY20	Y/Y Change
Operating Cash Flow	$15.3M	↓ 66.54%
Investing Cash Flow	$-68.3M	↑ 148.0%
Financing Cash Flow	$-1.4M	↓ 215.12%

	FY21	Y/Y Change
Operating Cash Flow	$3.3M	↓ 78.24%
Investing Cash Flow	$-105.5M	↑ 54.39%
Financing Cash Flow	$194.6M	↓ 13622.93%

	FY22	Y/Y Change
Operating Cash Flow	$-31.2M	↓ 1039.28%
Investing Cash Flow	$-15.7M	↓ 85.08%
Financing Cash Flow	$-5.1M	↓ 102.63%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$20.6M	↓ 3.72%
Investing Cash Flow	$-6.8M	↑ 190.1%
Financing Cash Flow	$80.2M	↓ 1862.31%

Ani Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Ani Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Ani Pharmaceuticals Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Ani Pharmaceuticals Inc	-4.49%	-15.07%	-0.15%	8.39%	-16.43%
Neurocrine Biosciences Inc.	8.34%	1.35%	5.43%	59.49%	24.91%
Zoetis Inc.	-6.72%	-4.07%	-15.46%	-31.76%	24.53%
Haleon Plc Spon Ads	1.47%	12.15%	18.9%	30.77%	30.77%
Viatris Inc.	-5.51%	19.58%	17.56%	-5.51%	-23.38%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Ani Pharmaceuticals Inc	49.06	NA	1.06	-0.26	-0.02	0.01	NA	20.74
Neurocrine Biosciences Inc.	35.99	35.99	0.32	6.54	0.16	0.12	NA	26.87
Zoetis Inc.	30.68	30.68	2.6	5.88	0.47	0.15	0.01	11.59
Haleon Plc Spon Ads	28.53	28.53	1.73	0.34	0.07	0.04	0.02	1.82
Viatris Inc.	224.4	NA	0.07	2.69	-0.04	0.02	0.04	16.58

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Ani Pharmaceuticals Inc	Buy	$1.1B	-16.43%	49.06	-1.28%
Neurocrine Biosciences Inc.	Buy	$13.7B	24.91%	35.99	17.21%
Zoetis Inc.	Buy	$73.8B	24.53%	30.68	26.55%
Haleon Plc Spon Ads	Buy	$44.1B	30.77%	28.53	10.75%
Viatris Inc.	Hold	$14.5B	-23.38%	224.4	-5.87%

About Ani Pharmaceuticals

ani pharmaceuticals is an integrated specialty pharmaceutical company focused on delivering value to our customers by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals. we focus on niche and high barrier to entry opportunities including controlled substances, anti-cancer (oncolytics), hormones and steroids, and complex formulations. our two pharmaceutical manufacturing facilities located in baudette, minnesota are capable of producing oral solid dose products, as well as liquids and topicals, controlled substances, and potent products that must be manufactured in a fully-contained environment. our objective is to create long term shareholder value by building a sustainable and growing base business in generic and mature brand pharmaceutical products while advancing an opportunity to re-commercialize cortrophin gel and cortrophin-zinc.

Organization	Ani Pharmaceuticals
Employees	642
CEO	Mr. Nikhil Lalwani
Industry	Health Technology

Management People of Ani Pharmaceuticals

Name	Title
Mr. Nikhil Lalwani	President, CEO & Director
Mr. Stephen P. Carey	Senior VP of Finance & CFO
Mr. Chad Gassert	Senior Vice President of Corporate Development & Strategy
Mr. Christopher K. Mutz	Senior VP & Head of Rare Disease
Mr. Ori Gutwerg	Senior Vice President of Generics
Mr. Muthusamy Shanmugam MS R.Ph.	Head of R&D, COO of Novitium Operations & Director
Mr. James G. Marken	Senior Vice President of Operations
Ms. Elizabeth Powell J.D.	Chief Compliance Officer & Head of Legal of Rare Disease
Ms. Meredith W. Cook J.D.	Senior VP, General Counsel & Corporate Secretary
Ms. Krista L. Davis	Senior VP & Chief Human Resources Officer

Important FAQs about investing in Ani Pharmaceuticals from India :

What is Ani Pharmaceuticals share price today?

Ani Pharmaceuticals share price today stands at $53.35, Open: $53.69 ; Previous Close: $54.26 ; High: $54.51 ; Low: $53.01 ; 52 Week High: $70.81 ; 52 Week Low: $52.00. The stock opens at $53.69, after a previous close of $54.26. The stock reached a daily high of $54.51 and a low of $53.01, with a 52-week high of $70.81 and a 52-week low of $52.00.

Can Indians buy Ani Pharmaceuticals shares?

Yes, Indians can invest in the Ani Pharmaceuticals (ANIP) from India.

With INDmoney, you can buy Ani Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Ani Pharmaceuticals at zero transaction cost.

How can I buy Ani Pharmaceuticals shares from India?

It is very easy to buy Ani Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Ani Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Ani Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Ani Pharmaceuticals stocks?

To start investing in Ani Pharmaceuticals, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.